Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06652958
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-27
Brief Title:
A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody VH4527079 in Healthy Adults and Persons With HIV
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Open-Label Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody VH4527079 Administered Either Intravenously or Subcutaneously to Healthy Adults and Persons With HIV
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the safety tolerability and pharmacokinetics PK of a single dose administration of VH4527079 by subcutaneous SC injection or by intravenous IV infusion in healthy adult participants and multiple dose administration by IV infusion in healthy adult participants and in Persons with HIV PWH
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None